Lonza Group AG (SWX:LONN)
475.70
-7.00 (-1.45%)
Apr 29, 2026, 3:50 PM CET
Lonza Group AG Revenue
In the year 2025, Lonza Group AG had annual revenue of 6.53B CHF with 19.18% growth.
Revenue
6.53B
Revenue Growth
-1.57%
P/S Ratio
5.16
Revenue / Employee
326.55K
Employees
20,000
Market Cap
33.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.53B | 1.05B | 19.18% |
| Dec 31, 2024 | 5.48B | -1.24B | -18.42% |
| Dec 31, 2023 | 6.72B | 494.00M | 7.94% |
| Dec 31, 2022 | 6.22B | 814.00M | 15.05% |
| Dec 31, 2021 | 5.41B | 901.00M | 19.99% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Galderma Group AG | 4.16B |
| Alcon | 8.25B |
| Sandoz Group AG | 8.85B |
| Straumann Holding AG | 2.61B |
| Sonova Holding AG | 3.85B |
| Galenica AG | 4.15B |
Lonza Group AG News
- 7 weeks ago - Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG - Business Wire
- 2 years ago - Lonza chairman to step down, drugmaker confirms targets, shares soar - Reuters
- 2 years ago - Lonza CEO departure prompts concern over earnings prospects - Reuters
- 3 years ago - 10 Solid Stocks WIth Terrible Tickers - Barrons
- 4 years ago - Lonza's first-half core EBITDA gains 16.5% - Reuters
- 5 years ago - Lonza appoints Novartis executive as new Chief Financial Officer - Reuters
- 5 years ago - 12 European Stocks That Analysts Love and Investors Are Ignoring - Barrons
- 5 years ago - aTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810 - Benzinga